AG
Amol Ghate
About Amol Ghate
Data last updated:
Amol Ghate is a Director at Nexus Clinical Research (India) Limited (since 2017) and Director at Nexus Medquest India Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Nexus Clinical Research (India) Limited at ₹23,490 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Jul 2017 | 2005 | ₹23,490 (FY 2025) | Active | |
| Director | 19 Mar 2025 | 2025 | Active |
Board colleagues of Amol Ghate
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Bhatt | 07859111 | Nexus Clinical Research (India) Limited , Nexus Medquest India Private Limited | Director |
| Meghna Amit Bhatt | 01070094 | Nexus Clinical Research (India) Limited | Director |
| Murtuza Raza Husain Shaikh | 09640903 | Nexus Medquest India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amol Ghate
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amol Ghate
Amol Ghate currently holds 2 directorships: Nexus Clinical Research (India) Limited (Director, since 04 Jul 2017, revenue ₹23,490 (FY 2025)); Nexus Medquest India Private Limited (Director, since 19 Mar 2025).
Amol Ghate was first appointed on 04 Jul 2017 as Director at Nexus Clinical Research (India) Limited. The most recent appointment on record is 19 Mar 2025 at Nexus Medquest India Private Limited.
The current boards of Amol Ghate's companies include Amit Bhatt (Nexus Clinical Research (India) Limited), Meghna Amit Bhatt (Nexus Clinical Research (India) Limited), Murtuza Raza Husain Shaikh (Nexus Medquest India Private Limited).